Argent BioPharma Limited (RGTLF)

Argent BioPharma Revenue

Argent BioPharma had revenue of 4.28K AUD in the half year ending December 31, 2024, a decrease of -99.84%. This brings the company's revenue in the last twelve months to 295.83K, down -77.66% year-over-year. In the fiscal year ending June 30, 2024, Argent BioPharma had annual revenue of 891.08K, down -73.70%.

• Revenue (ttm): 295.83K AUD
• Revenue Growth: -77.66%
• P/S Ratio: 24.90
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.56M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	891.08K	-2.50M	-73.70%
Jun 30, 2023	3.39M	-1.34M	-28.41%
Jun 30, 2022	4.73M	1.74M	57.94%
Jun 30, 2021	3.00M	916.88K	44.10%
Jun 30, 2020	2.08M	1.42M	216.83%